Medtronic Inc said it bought disease management and patient monitoring firm Cardiocom LLC for $200 million, the Wall Street Journal reported. The deal puts the medical device maker in the business of working with hospitals to cut costs in treating patients with chronic diseases such as heart failure and diabetes, and caring for patients who don't require expensive, implantable devices, the newspaper said, without citing any sources. ()Medtronic could not be reached for immediate comment by Reuters outside of regular U.S. business hours.
Medtronic, Inc. (Medtronic) is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. Shares of MDT remained unchanged at $55.37. In the past year, the shares have traded as low as $36.91 and as high as $53.83. On average, 4676060 shares of MDT exchange hands on a given day and today's volume is recorded at 0.
Source
